title: Relationship between lipoprotein- and oxidation-related variables and atheroma lipid composition in subjects undergoing coronary artery bypass graft surgery.
abstract: The relationship between atheroma lipid composition and serum lipoprotein and oxidation measurements has not been fully explored. To address this question, we studied serum, plasma, and aortic wall specimens from 66 subjects undergoing coronary artery bypass graft surgery. The lipid composition of aortic specimens was characterized in terms of cholesterol ester and cholesterol crystal plus phospholipid by using hot-stage polarizing light microscopy; tissue oxidation status was assessed by measuring conjugated dienes. Serum lipoprotein-related measurements included total cholesterol, triglyceride, low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, apolipoproteins B and AI, and lipoprotein(a). Oxidation status was assessed by measuring LDL mobility, thiobarbituric acid-reactive substances, LDL conjugated dienes, and IgG and IgM autoantibodies against oxidized LDL. Fasting blood glucose was also determined. Lesion cholesterol crystal plus phospholipid content was associated inversely with serum HDL cholesterol levels (r=-0.279, P=0.029) and positively with fasting blood glucose (r=0.359, P=0.016), LDL mobility (0.276, P<0.05), and IgM autoantibodies against oxidized LDL (r=0.272, P=0.037). There was also a significant relationship between the level of aortic tissue conjugated dienes and plasma LDL mobility (r=0.332, P=0.007). In multivariate analysis, IgM autoantibodies against oxidized LDL, fasting blood glucose, and LDL mobility, in descending order of significance, together accounted for 35% of the variability in aortic lesion cholesterol crystal plus phospholipid content. These data support direct and independent roles for oxidation and hyperglycemia in the pathophysiology of atherosclerosis.
authors.affiliation: Foundation for Blood Research, Scarborough, Maine, USA.
authors.forename: W Y
authors.initials: WY
authors.lastname: Craig
authors.forename: M W
authors.initials: MW
authors.lastname: Rawstron
authors.forename: C A
authors.initials: CA
authors.lastname: Rundell
authors.forename: E
authors.initials: E
authors.lastname: Robinson
authors.forename: S E
authors.initials: SE
authors.lastname: Poulin
authors.forename: L M
authors.initials: LM
authors.lastname: Neveux
authors.forename: P M
authors.initials: PM
authors.lastname: Nishina
authors.forename: L M
authors.initials: LM
authors.lastname: Keilson
mesh_terms: D000368:Aged; D001161:Arteriosclerosis / Q000378:metabolism*; D001323:Autoantibodies / Q000097:blood; D002788:Cholesterol Esters / Q000378:metabolism; D001026:Coronary Artery Bypass; D005260:Female; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D008055:Lipids / Q000032:analysis*; D008074:Lipoproteins / Q000378:metabolism*; D008077:Lipoproteins, LDL / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction
chemical_list: D001323:Autoantibodies; D002788:Cholesterol Esters; D007075:Immunoglobulin M; D008055:Lipids; D008074:Lipoproteins; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein